These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7300021)

  • 21. Pressor responses to vasopressin in pigs and sheep with DOCA hypertension.
    Ling WD; Brooks DP; Crofton JT; Share L; Bohr DF
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H101-4. PubMed ID: 2912171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vasopressin in hypertension.
    Share L; Crofton JT
    Fed Proc; 1984 Jan; 43(1):103-6. PubMed ID: 6690329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    Nicholas TE
    Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 2000 Jul; 400(2-3):231-7. PubMed ID: 10988339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.
    Risvanis J; Johnston CI; Phillips PA; Burrell LM
    Clin Sci (Lond); 1998 May; 94(5):517-23. PubMed ID: 9682675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension.
    Share L; Crofton JT; Ouchi Y
    Am J Med Sci; 1988 Apr; 295(4):314-9. PubMed ID: 3364463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness of locus ceruleus neurons in hypertensive rats to vasopressin.
    Berecek KH; Olpe HR; Hofbauer KG
    Hypertension; 1987 Jun; 9(6 Pt 2):III110-3. PubMed ID: 3596777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats.
    Fareh J; Touyz RM; Schiffrin EL; Thibault G
    Hypertension; 1997 Nov; 30(5):1253-9. PubMed ID: 9369284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.
    Crofton JT; Share L; Shade RE; Lee-Kwon WJ; Manning M; Sawyer WH
    Hypertension; 1979; 1(1):31-8. PubMed ID: 544512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressor responsiveness to and secretion of vasopressin during the estrous cycle.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R1041-8. PubMed ID: 3202219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats.
    Gutkind JS; Kurihara M; Saavedra JM
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H646-50. PubMed ID: 3414825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats.
    Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H
    Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension.
    Li L; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the sympathetic nervous system and vasopressin on the blood pressure lowering effect of nifedipine in deoxycorticosterone acetate-salt hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Sci (Lond); 1987 Sep; 73(3):253-8. PubMed ID: 3652632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.